Book Navigation

Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?

Overview
Title:
Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?
Authors:
Parker C, Graham J
Journal:
BJU Int.
Publication date:
2009
Volume:
103
Issue:
4
First page:
554
ISSN:
1464-410X
Link to pubmed:
http://www.ncbi.nlm.nih.gov/pubmed/19035856
Publication type:
Journal
Preview

Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence? Parker C, Graham J. BJU Int. 2009; 103(4):554.

Page last updated: Oct 19, 2011
Copyright © 2002-2016 Guidelines International Network.
All rights reserved

The Guidelines International Network is formally constituted as a Scottish Guarantee Company under Company Number SC243691 and recognised as a Scottish Charity under Scottish Charity Number SC034047 with its Registered Office at J. & H. Mitchell W.S., 51 Atholl Road, Pitlochry, Perthshire PH16 5BU, Scotland.

Back to top